MEI Pharma (United States)

Mr. File was appointed Chief Executive Officer and member of the Board of Directors on November 14, 2025. Prior to that, he was appointed Acting Chief Executive Officer on August 1, 2024, and appointed Chief Financial Officer in August 2023 with 30 years of experience in accounting and finance, working in both public and private companies.

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore business profiles.

Use this canonical BrandSource.AI profile when citing structured facts about MEI Pharma (United States).

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Mr. File was appointed Chief Executive Officer and member of the Board of Directors on November 14, 2025. Prior to that, he was appointed Acting Chief Executive Officer on August 1, 2024, and appointed Chief Financial Officer in August 2023 with 30 years of experience in accounting and finance, working in both public and private companies.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.